Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 350

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis

Open access
Weber, Georg F., Chousterman, Benjamin G., He, Shun, Fenn, Ashley M., Nairz, Manfred, Anzai, Atsushi, Brenner, Thorsten, Uhle, Florian, Iwamoto, Yoshiko, Robbins, Clinton S., Noiret, Lorette, Maier, Sarah L., Zönnchen, Tina, Rahbari, Nuh N., Schölch, Sebastian, Klotzsche-von Ameln, Anne, Chavakis, Triantafyllos, Weitz, Jürgen, Hofer, Stefan, Weigand, Markus A., Nahrendorf, Matthias, Weissleder, Ralph, Swirski, Filip K.·2015·Science

Abstract

A new therapeutic target for sepsis: Infections can sometimes unleash powerful immune responses that careen out of control, leading to sepsis, organ failure, and death. Although antibiotics can help to quash the infection, sepsis patients also need therapies that will rein in the immune response. Weber et al. now identify one potential target, the secreted protein interleukin-3 (IL-3) (see the Perspective by Hotchkiss). In sepsis patients, higher serum concentrations of IL-3 were correlated with higher rates of mortality. In septic mice, IL-3 caused the immune system to produce large amounts of cells called monocytes and neutrophils, which secrete highly inflammatory proteins. Blocking IL-3 protected mice from sepsis-induced death. Science , this issue p. 1260 ; see also p. 1201

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.aaa4268

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 33 references

Cited by

See all 350

Metadata

Authors
Weber, G. F., Chousterman, B. G., He, S., Fenn, A. M., Nairz, M., Anzai, A., Brenner, T., Uhle, F., Iwamoto, Y., Robbins, C. S., Noiret, L., Maier, S. L., Zönnchen, T., Rahbari, N. N., Schölch, S., Klotzsche-von Ameln, A., Chavakis, T., Weitz, J., Hofer, S., Weigand, M. A., Nahrendorf, M., Weissleder, R., & Swirski, F. K.
Venue
Science
Published
2015-03-13
Volume
347
Issue
6227
Pages
1260-1265
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W2086143858
Cited by
350
References
33
FWCI
23.16
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. https://app.cochat.ai/papers/10.1126/science.aaa4268
The paper
Weber, G. F., Chousterman, B. G., He, S., Fenn, A. M., Nairz, M., Anzai, A., Brenner, T., Uhle, F., Iwamoto, Y., Robbins, C. S., Noiret, L., Maier, S. L., Zönnchen, T., Rahbari, N. N., Schölch, S., Klotzsche-von Ameln, A., Chavakis, T., Weitz, J., Hofer, S., . . . Swirski, F. K. (2015). Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis. Science. https://doi.org/10.1126/science.aaa4268

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.